Effects of Chronic, Systemic Treatment with the Dopamine Receptor Agonist R-Apomorphine in Partially Lesioned Rat Model of Parkinson's Disease: An Electrophysiological Study of Substantia Nigra Dopamine Neurons

Zhen-Hua Gui ； Jian Liu ； Yong Wang ； Umar Ali ； Tao Wang ； Li Chen

《The Chinese Journal of Physiology》 54卷2期 (2011/04) Pp. 96-104

https://doi.org/10.4077/CJP.2011.AMM014

並列摘要

Previous studies have suggested that R-apomorphine (R-APO), a non-selective dopamine (DA) receptor agonist, has neuroprotective effects in the experimental models of Parkinson's disease (PD). In this study, we investigated the effects of chronic, systemic treatment with R-APO in the firing activity of substantia nigra pars compacta (SNc) DA neurons in 6-hydroxydopamine (6-OHDA) partially lesioned rats. In the 6-OHDA-lesioned rats treated with vehicle, injection of 6-OHDA (20.1 μg) into the striatum produced a partial lesion causing 41% loss of tyrosine hydroxylase-immunoreactive (TH-ir) neurons in the SNc. In the partially lesioned rats, chronic, systemic treatment of R-APO (10 mg/kg/day, s.c., 11 days) attenuated loss of TH-ir neurons in the SNc. The partial lesion of the nigrostriatal pathway and R-APO treatment did not change the firing rate and firing pattern of DA neurons in the SNc of rats. In contrast, the R-APO treatment increased the number of spontaneously active DA neurons of the SNc in the partially lesioned rats, while the lesion decreased the number of spontaneously active DA neurons. In addition, the chronic R-APO treatment decreased the responsiveness of the DA neurons to intravenously administrated R-APO in the partially lesioned rats. These results indicate that chronic, systemic R-APO treatment has the neuroprotective effect, and reverses the decrease in the number of spontaneously active DA neurons in the SNc whereas the treatment induces a reduction in the sensitivity of DA receptors in the SNc to R-APO stimulation in this model.

並列關鍵字

apomorphine ； substantia nigra ； tyrosine hydroxylase ； extracellular recording ； Parkinson's disease

參考文獻

Acheson, A. L.,Zigmond, M. J.,Stricker, E. M.(1980).Compensatory increase in tyrosine-hydroxylase activity in rat-brain after intraventricular injections of 6-hydroxydopamine.Science.207,537-538.

Akaoka, H.,Charlety, P.,Saunier, C. F.,Buda, M.,Chouvet, G.(1992).Inhibition of nigral dopamine neurons by systemic and local apomorphine: Possible contribution of dendritic autoreceptors.Neuroscience.49,879-891.

Battaglia, G.,Busceti, C. L.,Cuomo, L.,Giorgi, F. S.,Orzi, F.,De Blasi, A.,Nicoletti, F.,Ruggieri, S.,Fornai, F.(2002).Continuous subcutaneous infusion of apomorphine rescues nigrostriatal dopaminergic terminals following MPTP injection in mice.Neuropharmacology.42,367-373.

Bilbao, G.,Ruiz-Ortega, J. A.,Miguens, N.,Ulibarri, I.,Linazasoro, G.,Gomez-Urquijo, S.,Garibi, J.,Ugedo, L.(2006).Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: Effects of subthalamotomy and levodopa treatment.Brain Res..1084,175-184.

Bozzi, Y.,Borrelli, E.(2006).Dopamine in neurotoxicity and neuro-protection: what do D2 receptors have to do with it?.Trends Neurosci..29,167-174.